Profiling 26S Proteasome Activity of Plasmodium falciparum Monitored by a Live-Cell Assay
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052104 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Adriana F Gonçalves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Plasmodium falciparum, Proteasome Endopeptidase Complex, Protozoan Proteins. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Foundation for Science and Technology.
Abstract (Originalsprache)
Malaria remains a major global health challenge, driven in part by widespread antimalarial drug resistance in Plasmodium parasites. Artemisinin-based combination therapies (ACTs) are currently the first-line treatment; however, resistance has also emerged. Artemisinin damages parasite proteins, promoting their ubiquitination and subsequent proteasomal degradation. Because inhibitors of the Plasmodium 26S proteasome synergize with artemisinin, the proteasome has emerged as a promising drug target, yet tools to monitor its function in live parasites remain limited. Here, we generated a P. falciparum line expressing green fluorescent protein fused to a destabilization domain (GFP-DD) to assess proteasome activity and combined it with MitoTrackerTM staining. In the absence of the stabilizing ligand Shield-1, the GFP-DD reporter is rapidly degraded by the proteasome. Using fluorescence microscopy and flow cytometry, we show that GFP-DD fluorescence provides a quantitative, inverse readout of proteasomal activity, increasing upon ligand-mediated stabilization or pharmacological inhibition with MG132. Shield-1 titration identified an optimal stabilization range, and MG132 induced a dose-dependent fluorescence increase. This work establishes a practical live-cell platform to probe ubiquitin–proteasome system function, with potential applications in future phenotypic screening and antimalarial resistance studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
- Life and Health Sciences Research Institute (ICVS)/Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
ORCID-Profile: Belém Sampaio-Marques, Pedro E Ferreira
Förderung
- Fundação para a Ciência e Tecnologia
- Foundation for Science and Technology
Zitieren
APA
Gonçalves, A. F., Lima-Pinheiro, A., Sampaio-Marques, B., & Ferreira, P. E. (2026). Profiling 26S Proteasome Activity of Plasmodium falciparum Monitored by a Live-Cell Assay. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052104
Vancouver
Gonçalves AF, Lima-Pinheiro A, Sampaio-Marques B, Ferreira PE. Profiling 26S Proteasome Activity of Plasmodium falciparum Monitored by a Live-Cell Assay. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052104
BibTeX
@article{Gonalves2026,
author = {Gonçalves, Adriana F and Lima-Pinheiro, Ana and Sampaio-Marques, Belém and Ferreira, Pedro E},
title = {Profiling 26S Proteasome Activity of Plasmodium falciparum Monitored by a Live-Cell Assay},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052104}
}
EUVIMED